Gemtesa

Active Ingredient(s): Vibegron
FDA Approved: * December 23, 2020
Pharm Company: * UROVANT
Category: Urinary System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Gemtesa Overview

Vibegron, sold under the brand name Gemtesa, is a medication for the treatment of overactive bladder.[1][2][3] Vibegron (other names: RVT-901; MK4618; KRP114V; URO-901) is a selective beta 3 adrenergic receptor agonist. The most common side effects include headache, urinary tract infection, common cold, diarrhea, nausea, and upper respiratory tract infection.[2] It was approved for medical use in the United States in December 202...

Read more Gemtesa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Vibegron

Recent Gemtesa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Vibegron or a similar ingredient: (1 result)

• VIBEGRON